Related Experiment Video
Updated: Aug 17, 2026
Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
Therapeutic advantages of AT1 blockers in hypertension
1Department of Medicine, Queen Elizabeth Hospital, Birmingham, England. m.j.kendall@bham.ac.uk
Insights
Angiotensin II receptor blockers (ARBs) show potential as ideal antihypertensive drugs. They effectively lower blood pressure and offer excellent tolerability, potentially reducing risks associated with high blood pressure.
Area of Science:
- Cardiovascular Pharmacology
- Hypertension Management
Background:
- Most antihypertensive medications have drawbacks, including adverse effects and limited evidence of organ protection.
- The ideal antihypertensive drug should effectively lower blood pressure, be well-tolerated, safe long-term, inexpensive, and reduce risks of myocardial infarction, stroke, and renal damage.
Purpose of the Study:
- To evaluate the potential of Angiotensin II receptor blockers (AT1 blockers) as ideal antihypertensive agents.
- To compare the benefits and tolerability of AT1 blockers with other antihypertensive drugs, particularly ACE inhibitors.
Main Methods:
- Review of existing pharmacological data and clinical evidence for antihypertensive drugs.
- Focus on drugs that reduce Angiotensin II effects, including ACE inhibitors and AT1 blockers.
Main Results:
- ACE inhibitors have demonstrated benefits in reducing coronary events, sudden death, heart failure, and renal damage.
- AT1 blockers provide similar pharmacological advantages to ACE inhibitors with superior tolerability, notably lacking the cough side effect.
Conclusions:
- AT1 blockers possess the pharmacological profile to meet the criteria for an ideal antihypertensive drug.
- Their efficacy in blood pressure reduction combined with excellent tolerability makes them a promising option for long-term hypertension management and organ protection.
Abstract:
Most antihypertensives have advantages and disadvantages. The ideal antihypertensive drug should be effective in lowering blood pressure, well tolerated, safe in the long term, and easy to use. Ideally, it should be relatively inexpensive. Most importantly it should reduce the risk of the adverse effects of high blood pressure, such as myocardial infarction, sudden death, stroke, heart failure, renal damage, and retinal changes. Most antihypertensive drugs effectively reduce blood pressure, are available as once daily preparations, and are safe long-term. Unfortunately, most antihypertensive drugs cause adverse effects in some patients and for few drugs is there good evidence that they protect the heart, the brain, the kidney, and the eye? Reducing the effects of Angiotensin II (using an ACE inhibitor) has been shown to reduce the incidence of coronary events, sudden death, heart failure, renal damage, and fundal changes. AT1 blocking drugs offer the same pharmacological advantages but also very good tolerability, in particular no cough. Therefore, they have the potential to meet all the criteria for an ideal antihypertensive drug.
Related Concept Videos
01:17Antihypertensive Drugs: Action of β1 Blockers
01:28Antihypertensive Drugs: Types of β-Blockers
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
01:25Antihypertensive Drugs: Direct Renin Inhibitors
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System